Kennedy Capital Management, Inc. Roivant Sciences Ltd. Transaction History
Kennedy Capital Management, Inc.
- $4.23 Billion
- Q4 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 52,908 shares of ROIV stock, worth $580,400. This represents 0.01% of its overall portfolio holdings.
Number of Shares
52,908
Previous 43,107
22.74%
Holding current value
$580,400
Previous $497,000
25.75%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$722 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$681 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$524 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$484 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$388 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.73B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...